A double-blind study of hyposensitization with an alginate-conjugated extract of Dermatophagoides pteronyssinus (Conjuvac) in patients with perennial rhinitis. II. Immunological aspects.
In a 2-year double-blind placebo controlled study an immunological evaluation was carried out on 33 patients (15 males, 18 females, mean age 29.2 years) with mite-induced perennial rhinitis who were submitted to specific immunotherapy (IT) with an alginate-conjugated extract of D. pteronyssinus. The behaviour of IgE, IgG, IgG1 and IgG4 antibodies specific to D. pteronyssinus and its major allergen Der p1 was characterized by assessment of their changes in serum, and changes in IgG in nasal secretions during the treatment. The placebo-treated patients did not show any significant variation in the levels of specific antibodies, while in the actively treated patients we found: a statistically significant decrease (P less than 0.005) of specific IgE, a statistically significant increase of specific IgG (P less than 0.005), IgG1 (P less than 0.005) and IgG4 (P less than 0.005) in serum and a statistically significant increase (P less than 0.001) of specific IgG in nasal secretions. The IgG response showed an early relative predominance of the IgG1 subclass and a late absolute predominance of IgG4 subclass, that confirmed the model of IgG4 restriction in prolonged allergen stimulation. No correlation was found between immunological and clinical data.
Pastorello
E A
EA
1st Department of Internal Medicine, University of Milan, Italy, UK.
Ortolani
C
C
Incorvaia
C
C
Farioli
L
L
Italia
M
M
Pravettoni
V
V
Harris
R J
RJ
Watson
H K
HK
Corrado
O J
OJ
Davies
R J
RJ
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D000818:Animals; D003888:Desensitization, Immunologic; D004311:Double-Blind Method; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D006023:Glycoproteins / Q000008:administration & dosage*; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D008297:Male; D008925:Mites / Q000276:immunology*; D009297:Nasal Mucosa / Q000276:immunology / Q000378:metabolism; D012221:Rhinitis, Allergic, Perennial / Q000276:immunology* / Q000628:therapy; D012680:Sensitivity and Specificity
D000276:Adjuvants, Immunologic; D006023:Glycoproteins; D007136:Immunoglobulins; C038866:conjuvac